Condensed Consolidated Statements of Convertible Preferred Stock and Stockholders' Deficit - USD ($) $ in Thousands	Total	Reverse Recapitalization [Member]	Stock Issued In Connection With Senior Secured Notes And Capital Market Advisory Agreements [Member]	Forward Purchase Agreement [Member]	Common Stock [Member]	Common Stock [Member] Reverse Recapitalization [Member]	Common Stock [Member] Stock Issued In Connection With Senior Secured Notes And Capital Market Advisory Agreements [Member]	Common Stock [Member] Forward Purchase Agreement [Member]	Additional Paid-in Capital [Member]	Additional Paid-in Capital [Member] Reverse Recapitalization [Member]	Additional Paid-in Capital [Member] Stock Issued In Connection With Senior Secured Notes And Capital Market Advisory Agreements [Member]	Additional Paid-in Capital [Member] Forward Purchase Agreement [Member]	Accumulated Other Comprehensive Loss [Member]	Accumulated Deficit [Member]	Convertible Preferred Stock [Member] Preferred Stock [Member]	Previously Reported [Member]	Previously Reported [Member] Common Stock [Member]	Previously Reported [Member] Additional Paid-in Capital [Member]	Previously Reported [Member] Accumulated Other Comprehensive Loss [Member]	Previously Reported [Member] Accumulated Deficit [Member]	Previously Reported [Member] Convertible Preferred Stock [Member] Preferred Stock [Member]	Revision of Prior Period, Adjustment [Member] Common Stock [Member]	Revision of Prior Period, Adjustment [Member] Convertible Preferred Stock [Member] Preferred Stock [Member]
Beginning balance at Dec. 31, 2022	$ (57,083)				$ 0				$ 2,734				$ (25)	$ (59,792)	$ 64,716	$ (57,083)	$ 0	$ 2,734	$ (25)	$ (59,792)	$ 64,716
Beginning balance, (in shares) at Dec. 31, 2022					4,656,228										13,001,114		5,095,831				14,222,580	(439,603)	(1,221,466)
Issuance of common stock resulting from exercise of stock options (in shares)					2,999
Issuance of common stock resulting from exercise of stock options	6								6
Stock-based compensation expense	45								45
Net loss	(5,068)				$ (5,068)									(5,068)
Cumulative translation adjustment	(1)												(1)
Ending balance at Mar. 31, 2023	(62,101)				$ 0				2,785				(26)	(64,860)	$ 64,716
Ending balance, (in shares) at Mar. 31, 2023					4,659,227										13,001,114
Beginning balance at Dec. 31, 2022	$ (57,083)				$ 0				2,734				(25)	(59,792)	$ 64,716	(57,083)	$ 0	2,734	(25)	(59,792)	$ 64,716
Beginning balance, (in shares) at Dec. 31, 2022					4,656,228										13,001,114		5,095,831				14,222,580	(439,603)	(1,221,466)
Issuance of common stock related to the conversion of Senior Secured Notes (Shares)	13,001,114
Ending balance at Dec. 31, 2023	$ (74,942)				$ 0				14,633				(49)	(89,526)	$ 64,716	$ (74,942)	$ 0	$ 14,633	$ (49)	$ (89,526)	$ 64,716		$ 0
Ending balance, (in shares) at Dec. 31, 2023					4,678,950										13,001,114		5,118,553				14,222,580	(439,603)	(1,221,466)
Issuance of common stock resulting from exercise of stock options (in shares)	47,183				47,183
Issuance of common stock resulting from exercise of stock options	$ 68								68
Stock-based compensation expense	191								191
Loss on issuance of Senior Secured Notes	9,776								9,776
Issuance of common stock (Value)		$ 4,478	$ 352	$ (10,986)		$ 1				$ 4,477	$ 352	$ (10,986)
Issuance of common stock (Shares)		7,596,206				7,596,206	42,372	500,000
Issuance of common stock related to the conversion of Senior Secured Notes (Value)	14,660								14,660
Issuance of common stock related to the conversion of Senior Secured Notes (Shares)					3,257,876
Conversion of redeemable convertible preferred stock into common stock in connection with the reverse recapitalization (Value)	64,716				$ 1				64,715
Conversion of redeemable convertible preferred stock into common stock in connection with the reverse recapitalization ((Shares)					13,001,114
Conversion of redeemable convertible preferred stock into common stock in connection with the reverse recapitalization (Shares)															(13,001,114)
Conversion of redeemable convertible preferred stock into common stock in connection with the reverse recapitalization (Value)															$ (64,716)
Issuance costs in connection with the reverse recapitalization		$ (7,058)								$ (7,058)
Net loss	(22,320)				$ (22,320)									(22,320)
Cumulative translation adjustment	(15)												(15)
Ending balance at Mar. 31, 2024	$ (21,080)				$ 2				$ 90,828				$ (64)	$ (111,846)	$ 0
Ending balance, (in shares) at Mar. 31, 2024					29,123,701										0